Haven't used Cardiora yet?
Ask AI

Ask AI about Cardiora

Generated with AI from 10 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="cardiora-com" data-lang="en"></div>
More widgets

About Cardiora

Cardiora is a clinical stage biopharmaceutical company that was established in 2015. Cardiora is focussed on developing new treatments for patients with end stage heart failure, which is associated with high mortality rates, recurrent hospital admissions and poor quality of life.

Cardiora’s lead program is currently in Phase Ib trials, and IND enabling trials are currently being completed. Cardiora intends to enter Phase II trials in 2017.